Insiders · Profile

ACKERMAN RICHARD

President and CEO at NRX Pharmaceuticals. Filing since 29 Nov 2017. CIK 0001724016

Company
Date
Role
Action
Shares
Amount
Of holding
20 Nov 2018
President and CEO
Sold, plan not stated
1,500,000
no price
87.0%
29 Nov 2017
President and CEO
Bought
22,500
$225.00K
9.0%
2 decisions on file.